In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 23rd, 2004 | 18 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.90 | 0.01 | -6.3 | 1 | 2 | 0 | 24 | 252.342 | 3 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
VGFR2-2-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 124 | 0.54 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 124 | 0.54 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 124 | 0.54 | Binding ≤ 10μM |
Description | Species |
---|---|
EPHA-mediated growth cone collapse | |
Integrin cell surface interactions | |
Neurophilin interactions with VEGF and VEGFR | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |